Fortunately it is still significantly vulnerable to vancomycin, which has been doctors’ first-line treatment against MRSA infections for 40 years. MRSA rarely resists vancomycin. Only 16 such ...
A registration statement (File No. 333-280501) relating to the Notes was filed and has been declared effective by the SEC. This offering is being made solely by means of a written prospectus ...